Gut bacteria boosts breast cancer treatment? new trial launches
NCT ID NCT07552181
First seen Apr 29, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This phase 2 trial tests whether adding a live bacteria supplement (MO-03) to standard chemotherapy and immunotherapy (pembrolizumab) can improve outcomes for 50 people with early-stage triple-negative breast cancer. Participants take the supplement twice daily until surgery, then are followed for 5 years. The main goal is to see if the combination leads to no cancer remaining at surgery (pathological complete response).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CS Cancer at Valley Oncology Medical Group
Tarzana, California, 91356, United States
Contact
Contact
Contact
-
Cedars-Sinai Medical Center Beverly Hills
Beverly Hills, California, 90211, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Hunt Cancer Institute, an Affiliate of CS Cancer
Torrance, California, 90505, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.